首頁 > 市場調查報告書 > 醫療設備

市場調查報告書

商品編碼

1672108

全球放射腫瘤學市場研究報告 - 產業分析、規模、佔有率、成長、趨勢和預測 2025 年至 2033 年

Global Radiation Oncology Market Research Report- Industry Analysis, Size, Share, Growth, Trends and Forecast 2025 to 2033

出版日期: 2025年03月01日 | 出版商:

Value Market Research | 英文 162 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

全球放射腫瘤學市場規模預計將從 2024 年的 95.8 億美元成長到 2033 年的 179.5 億美元，在 2026 年至 2033 年的預測期內呈現 7.23% 的強勁年複合成長率(CAGR)。

受癌症發病率不斷上升和對有效治療方式的需求不斷成長的推動，放射腫瘤學市場有望大幅成長。隨著全球癌症發生率持續上升，對先進放射治療解決方案的需求變得越來越迫切。放射腫瘤學涵蓋一系列技術，包括外束放射治療、近距離放射治療和立體定位放射外科治療，所有這些技術對於各種癌症類型的全面管理都至關重要。調強放射治療 (IMRT) 與影像導引放射治療 (IGRT) 等尖端技術的融合，正在提高治療的精準度和有效性，從而改善患者的治療效果並最大限度地減少副作用。

此外，放射腫瘤技術的進步正在推動市場創新。質子療法和其他粒子療法的發展正在徹底改變癌症治療，它們透過提供標靶輻射在有效治療腫瘤的同時保護健康組織。這些先進的治療方式對兒科患者和腫瘤位於關鍵結構附近的患者特別有益。隨著研究不斷探索放射腫瘤學的新應用和新技術，市場可能會進一步擴大，並受到提高治療效果和患者安全性的推動。

此外，對個人化醫療的日益重視正在塑造放射腫瘤學的格局。隨著醫療保健提供者擴大尋求根據基因和分子分析為個別患者量身定做治療方案，對符合個人化治療計劃的放射治療的需求預計會增加。這種趨勢在聯合治療中尤其重要，其中放射療法與免疫療法或標靶療法一起使用以增強治療效果。隨著放射腫瘤學市場不斷發展，技術進步、個人化治療方法和改善患者治療效果的關注的融合將在塑造其未來發展方面發揮關鍵作用。

我們的報告經過精心製作，為客戶提供有關各個行業和市場的全面且可操作的見解。每份報告都包含幾個關鍵部分，以確保徹底了解市場格局：

市場概覽：市場的詳細介紹，包括定義、分類和行業現狀概述。

市場動態：深入分析影響市場成長的關鍵促進因素、限制因素、機會與挑戰。本節探討技術進步、監管變化和新興趨勢等因素。

細分分析：根據產品類型、應用、最終用戶和地理位置等標準將市場細分為不同的細分市場。該分析強調了每個部分的表現和潛力。

競爭格局：對主要市場參與者的全面評估，包括其市場佔有率、產品組合、策略舉措和財務表現。本節深入介紹領先公司的競爭動態和關鍵策略。

市場預測：根據歷史資料和當前市場狀況，預測特定時期內的市場規模和成長趨勢。這包括定量分析和圖形表示來說明未來的市場軌跡。

區域分析：評估不同地理區域的市場表現，確定關鍵市場和區域趨勢。這有助於了解區域市場動態和機會。

新興趨勢與機會：識別當前和新興的市場趨勢、技術創新和潛在投資領域。本節提供未來市場發展和成長前景的見解。

區域展望
介紹
北美銷售分析
- 概述、歷史和預測數據銷售分析
- 北美各細分市場銷售分析
- 北美各國銷售分析
- 美國銷售分析
- 加拿大銷售分析
- 墨西哥銷售分析
歐洲銷售分析
- 概述、歷史和預測數據銷售分析
- 歐洲各細分市場銷售分析
- 歐洲各國銷售分析
- 英國銷售分析
- 法國銷售分析
- 德國銷售分析
- 義大利銷售分析
- 俄羅斯銷售分析
- 歐洲其他地區銷售分析
亞太地區銷售分析
- 概述、歷史和預測數據銷售分析
- 亞太地區分部銷售分析
- 亞太地區國家銷售分析
- 中國銷售分析
- 印度銷售分析
- 日本銷售分析
- 韓國銷售分析
- 澳洲銷售分析
- 東南亞銷售分析
- 亞太地區其他地區銷售分析
拉丁美洲銷售分析
- 概述、歷史和預測數據銷售分析
- 拉丁美洲各細分市場銷售分析
- 拉丁美洲各國銷售分析
- 巴西銷售分析
- 阿根廷銷售分析
- 秘魯銷售分析
- 智利銷售分析
- 拉丁美洲其他地區銷售分析
中東和非洲銷售分析
- 概述、歷史和預測數據銷售分析
- 中東和非洲分部銷售分析
- 中東和非洲國家銷售分析
- 沙烏地阿拉伯銷售分析
- 阿拉伯聯合大公國銷售分析
- 以色列銷售分析
- 南非銷售分析
- 中東和非洲其他地區銷售分析

第 9 章：放射腫瘤學公司的競爭格局

放射腫瘤學市場競爭
夥伴關係/合作/協議
合併與收購
新產品發布
其他進展

第10章：公司簡介

頂級公司市佔率分析
市場集中度
Siemens Healthineers

公司概況
公司收入
產品
最新動態

GE Healthcare

公司概況
公司收入
產品
最新動態

Philips Healthcare

公司概況
公司收入
產品
最新動態

Varian Medical Systems

公司概況
公司收入
產品
最新動態

Elekta

公司概況
公司收入
產品
最新動態

Hitachi Medical Corporation

公司概況
公司收入
產品
最新動態

IBA Worldwide

公司概況
公司收入
產品
最新動態

Accuray Incorporated

公司概況
公司收入
產品
最新動態

Advanced Accelerator Applications

公司概況
公司收入
產品
最新動態

Nordion Inc

公司概況
公司收入
產品
最新動態

注意 - 在公司簡介中，財務細節和最新發展取決於可用性，對於私人公司，可能不予涵蓋

簡介目錄圖表

Product Code: VMR11219481

Global Radiation Oncology Market size is anticipated to grow from USD 9.58 Billion in 2024 to USD 17.95 Billion by 2033, showcasing a robust Compound Annual Growth Rate (CAGR) of 7.23% during the forecast period of 2026 to 2033.

The radiation oncology market is poised for significant growth, driven by the increasing incidence of cancer and the rising demand for effective treatment modalities. As cancer rates continue to escalate globally, the need for advanced radiation therapy solutions is becoming more critical. Radiation oncology encompasses a range of techniques, including external beam radiation therapy, brachytherapy, and stereotactic radiosurgery, all of which are essential in the comprehensive management of various cancer types. The integration of cutting-edge technologies, such as intensity-modulated radiation therapy (IMRT) and image-guided radiation therapy (IGRT), is enhancing the precision and effectiveness of treatment, thereby improving patient outcomes and minimizing side effects.

Moreover, advancements in radiation oncology technologies are driving innovation within the market. The development of proton therapy and other particle therapies is revolutionizing cancer treatment by providing targeted radiation that spares healthy tissues while effectively treating tumors. These advanced modalities are particularly beneficial for pediatric patients and those with tumors located near critical structures. As research continues to explore new applications and techniques in radiation oncology, the market is likely to expand further, fueled by the promise of improved therapeutic efficacy and patient safety.

Additionally, the growing emphasis on personalized medicine is shaping the radiation oncology landscape. As healthcare providers increasingly seek to tailor treatments to individual patients based on genetic and molecular profiling, the demand for radiation therapy that aligns with personalized treatment plans is expected to rise. This trend is particularly relevant in the context of combination therapies, where radiation is used alongside immunotherapy or targeted therapies to enhance treatment effectiveness. As the radiation oncology market continues to evolve, the convergence of technological advancements, personalized treatment approaches, and a focus on improving patient outcomes will play a crucial role in shaping its future trajectory.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

SEGMENTATION COVERED IN THE REPORT

By Product Type

External Beam Radiation Therapy
Internal Beam Radiation Therapy
Systemic Radiation Therapy

By Application

Breast Cancer
Lung Cancer
Prostate Cancer
Colorectal Cancer
Head and Neck Cancer
Others

By End-User

Hospitals
Ambulatory Radiotherapy Centers
Cancer Research Institutes
Others
COMPANIES PROFILED
Siemens Healthineers
GE Healthcare
Philips Healthcare
Varian Medical Systems
Elekta
Hitachi Medical Corporation
IBA Worldwide
Accuray Incorporated
Advanced Accelerator Applications
Nordion Inc.
The above list can be customized.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. RADIATION ONCOLOGY a€" INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porters Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Product Type
- 3.7.2 Market Attractiveness Analysis By Application
- 3.7.3 Market Attractiveness Analysis By End-User
- 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL RADIATION ONCOLOGY MARKET ANALYSIS BY PRODUCT TYPE

5.1. Overview By Product Type
5.2. Historical and Forecast Data Analysis By Product Type
5.3. External Beam Radiation Therapy Historic and Forecast Sales By Regions
5.4. Internal Beam Radiation Therapy Historic and Forecast Sales By Regions
5.5. Systemic Radiation Therapy Historic and Forecast Sales By Regions

6. GLOBAL RADIATION ONCOLOGY MARKET ANALYSIS BY APPLICATION

6.1. Overview By Application
6.2. Historical and Forecast Data Analysis By Application
6.3. Breast Cancer Historic and Forecast Sales By Regions
6.4. Lung Cancer Historic and Forecast Sales By Regions
6.5. Prostate Cancer Historic and Forecast Sales By Regions
6.6. Colorectal Cancer Historic and Forecast Sales By Regions
6.7. Head and Neck Cancer Historic and Forecast Sales By Regions
6.8. Others Historic and Forecast Sales By Regions

7. GLOBAL RADIATION ONCOLOGY MARKET ANALYSIS BY END-USER

7.1. Overview By End-User
7.2. Historical and Forecast Data Analysis By End-User
7.3. Hospitals Historic and Forecast Sales By Regions
7.4. Ambulatory Radiotherapy Centers Historic and Forecast Sales By Regions
7.5. Cancer Research Institutes Historic and Forecast Sales By Regions
7.6. Others Historic and Forecast Sales By Regions

8. GLOBAL RADIATION ONCOLOGY MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
- 8.3.1 Overview, Historic and Forecast Data Sales Analysis
- 8.3.2 North America By Segment Sales Analysis
- 8.3.3 North America By Country Sales Analysis
- 8.3.4 United States Sales Analysis
- 8.3.5 Canada Sales Analysis
- 8.3.6 Mexico Sales Analysis
8.4. Europe Sales Analysis
- 8.4.1 Overview, Historic and Forecast Data Sales Analysis
- 8.4.2 Europe By Segment Sales Analysis
- 8.4.3 Europe By Country Sales Analysis
- 8.4.4 United Kingdom Sales Analysis
- 8.4.5 France Sales Analysis
- 8.4.6 Germany Sales Analysis
- 8.4.7 Italy Sales Analysis
- 8.4.8 Russia Sales Analysis
- 8.4.9 Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
- 8.5.1 Overview, Historic and Forecast Data Sales Analysis
- 8.5.2 Asia Pacific By Segment Sales Analysis
- 8.5.3 Asia Pacific By Country Sales Analysis
- 8.5.4 China Sales Analysis
- 8.5.5 India Sales Analysis
- 8.5.6 Japan Sales Analysis
- 8.5.7 South Korea Sales Analysis
- 8.5.8 Australia Sales Analysis
- 8.5.9 South East Asia Sales Analysis
- 8.5.10 Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
- 8.6.1 Overview, Historic and Forecast Data Sales Analysis
- 8.6.2 Latin America By Segment Sales Analysis
- 8.6.3 Latin America By Country Sales Analysis
- 8.6.4 Brazil Sales Analysis
- 8.6.5 Argentina Sales Analysis
- 8.6.6 Peru Sales Analysis
- 8.6.7 Chile Sales Analysis
- 8.6.8 Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
- 8.7.1 Overview, Historic and Forecast Data Sales Analysis
- 8.7.2 Middle East & Africa By Segment Sales Analysis
- 8.7.3 Middle East & Africa By Country Sales Analysis
- 8.7.4 Saudi Arabia Sales Analysis
- 8.7.5 UAE Sales Analysis
- 8.7.6 Israel Sales Analysis
- 8.7.7 South Africa Sales Analysis
- 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE RADIATION ONCOLOGY COMPANIES

9.1. Radiation Oncology Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10. COMPANY PROFILES OF RADIATION ONCOLOGY INDUSTRY

10.1. Top Companies Market Share Analysis
10.2. Market Concentration Rate
10.3. Siemens Healthineers
- 10.3.1 Company Overview
- 10.3.2 Company Revenue
- 10.3.3 Products
- 10.3.4 Recent Developments
10.4. GE Healthcare
- 10.4.1 Company Overview
- 10.4.2 Company Revenue
- 10.4.3 Products
- 10.4.4 Recent Developments
10.5. Philips Healthcare
- 10.5.1 Company Overview
- 10.5.2 Company Revenue
- 10.5.3 Products
- 10.5.4 Recent Developments
10.6. Varian Medical Systems
- 10.6.1 Company Overview
- 10.6.2 Company Revenue
- 10.6.3 Products
- 10.6.4 Recent Developments
10.7. Elekta
- 10.7.1 Company Overview
- 10.7.2 Company Revenue
- 10.7.3 Products
- 10.7.4 Recent Developments
10.8. Hitachi Medical Corporation
- 10.8.1 Company Overview
- 10.8.2 Company Revenue
- 10.8.3 Products
- 10.8.4 Recent Developments
10.9. IBA Worldwide
- 10.9.1 Company Overview
- 10.9.2 Company Revenue
- 10.9.3 Products
- 10.9.4 Recent Developments
10.10. Accuray Incorporated
- 10.10.1 Company Overview
- 10.10.2 Company Revenue
- 10.10.3 Products
- 10.10.4 Recent Developments
10.11. Advanced Accelerator Applications
- 10.11.1 Company Overview
- 10.11.2 Company Revenue
- 10.11.3 Products
- 10.11.4 Recent Developments
10.12. Nordion Inc
- 10.12.1 Company Overview
- 10.12.2 Company Revenue
- 10.12.3 Products
- 10.12.4 Recent Developments